Zobrazeno 1 - 10
of 418
pro vyhledávání: '"Chih-Chi Wang"'
Autor:
Ting-Lung Lin, Po-Hsun Chang, Yueh-Wei Liu, Wei-Hung Lai, Ying-Ju Chen, I-Ling Chen, Wei-Feng Li, Chih-Chi Wang, Ing-Kit Lee
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 13, Iss 1, Pp 1-14 (2024)
Abstract Background Stenotrophomonas maltophilia, a multidrug-resistant gram-negative bacteria (GNB), is an emerging nosocomial pathogen. This study assessed the clinical outcomes of GNB infections in surgical intensive care unit (SICU) patients post
Externí odkaz:
https://doaj.org/article/8ed3117f2b1b40e1a31417f6cec219d1
Autor:
Wei-Ru Cho, Chih-Chi Wang, Mu-Jung Tsai, Chih-Che Lin, Yi-Hao Yen, Chien Hung Chen, Yuan-Hung Kuo, Chih-Chien Yao, Chao-Hung Hung, Pao-Yuan Huang, An-Che Liu, Ming-Chao Tsai
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 18 (2024)
Background: The risk of first recurrence of hepatocellular carcinoma (HCC) within years 5 to 10 after curative hepatectomy remains unknown. We aimed to assess the incidence and prognostic factors for very late recurrence among patients who achieved 5
Externí odkaz:
https://doaj.org/article/bbb17fa5e8f546c48bec8f2975145a64
Autor:
Po-Hsun Chang, Ting-Lung Lin, Ying-Ju Chen, Wei-Hung Lai, I-Ling Chen, Hui-Chuan Chang, Yu-Cheng Lin, Yu-Hung Lin, Wei-Feng Li, Yueh-Wei Liu, Chih-Chi Wang, Shih-Feng Liu
Publikováno v:
Microorganisms, Vol 12, Iss 7, p 1422 (2024)
Ventilator-associated pneumonia (VAP) is a critical hospital-acquired infection following non-cardiac surgeries, leading to poor outcomes. This study identifies VAP risk factors in non-cardiac surgical patients and determines the causative pathogens.
Externí odkaz:
https://doaj.org/article/b2728034e7784d3d9ff5befdc9c1fe62
Autor:
Yen-Hao Chen, Ching-Hua Tsai, Yen-Yang Chen, Chih-Chi Wang, Jing-Houng Wang, Chao-Hung Hung, Yuan-Hung Kuo
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Nivolumab and pembrolizumab have not been directly compared in clinical trials, and the aim of this study is to investigate the efficacy and safety of nivolumab versus pembrolizumab in patients with advanced hepatocellular carcino
Externí odkaz:
https://doaj.org/article/4968e9b4155e4e21abbd173f7d0859eb
Autor:
Wei-Juo Tzeng, Yu-Hung Lin, Teng-Yuan Hou, Shih‑Min Yin, Yu-Cheng Lin, Yueh-Wei Liu, Yu-Yin Liu, Wei-Feng Li, Chih-Chi Wang, Jacques Marescaux, Michele Diana
Publikováno v:
BMC Surgery, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background The treatment of common bile duct (CBD) stones with minimally invasive surgery (MIS) is more technical demanding than laparoscopic cholecystectomy (LC), especially in patients with history of previous abdominal surgery, cholangiti
Externí odkaz:
https://doaj.org/article/76afde6182a846d99060e67cf81913da
Autor:
Yi-Hao Yen, Kwong-Ming Kee, Tsung-Hui Hu, Ming-Chao Tsai, Yuan-Hung Kuo, Wei-Feng Li, Yueh-Wei Liu, Chih-Chi Wang, Chih-Yun Lin
Publikováno v:
PLoS ONE, Vol 19, Iss 3, p e0290523 (2024)
BackgroundWhether the etiology of chronic liver disease (CLD) impacts the overall survival (OS) of patients with hepatocellular carcinoma (HCC) remains unclear. We aim to clarify this issue.Materials and methodsBetween 2011 and 2020, 3941 patients wh
Externí odkaz:
https://doaj.org/article/4f15f10721dc46be9b6cafc213ae8dd0
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background The approved dose of nivolumab is 3 mg/kg or a flat dose of 240 mg for indications. There is no dose-response relationship for nivolumab; therefore, a low-dose regimen may be an option to reduce financial toxicity. This study was
Externí odkaz:
https://doaj.org/article/3582882d69f245ae8e833de29eb529ff
Autor:
Shu-Hsien Lin, Kun-Ta Wu, Chih-Chi Wang, Kuang-Tzu Huang, Li-Wen Hsu, Hock-Liew Eng, King-Wah Chiu
Publikováno v:
Antibodies, Vol 13, Iss 1, p 7 (2024)
Background and Aims: The impact of antibody responses following direct-acting antiviral (DAA) therapy in hepatitis C virus (HCV)-infected recipients before and after liver transplantation (LT) is still undetermined. Methods: In this observational coh
Externí odkaz:
https://doaj.org/article/422131f9bb004a1cb377c4ae4d89ed54
Autor:
Hsiang-Yu Tseng, Yu-Hung Lin, Chih-Che Lin, Chao-Long Chen, Chee-Chien Yong, Li-Man Lin, Chih-Chi Wang, Yi-Chia Chan
Publikováno v:
Frontiers in Surgery, Vol 10 (2023)
Background and aimsHepatorenal syndrome (HRS) is a disastrous renal complication of advanced liver disease with a poor prognosis. Restoring normal liver function through liver transplantation (LT) is a standardized treatment with favorable short-term
Externí odkaz:
https://doaj.org/article/d306b8d429f34cad83112894f84ef0c2
Autor:
Yi-Chia Chan, Chao-Long Chen, Chih-Chi Wang, Chih-Che Lin, Chee-Chien Yong, King-Wah Chiu, Keng-Liang Wu
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Liver cirrhosis is a well-known risk factor of sepsis after emergent gastrointestinal (GI) endoscopy. Elective GI endoscopy before living donor liver transplantation (LDLT), however, may also carry the septic risk among these pati
Externí odkaz:
https://doaj.org/article/e585770a3fc54ee4af2c29a6412d1351